United States - English - NLM (National Library of Medicine)

liebel-flarsheim company llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37) - sodium chloride .9 mg in 1 ml - - 125 ml syringe:  sodium chloride injection usp 0.9% is indicated for use in flushing compatible contrast agents through liebel-flarsheim intravenous administration sets into indwelling intravascular access devices only when delivered by the following liebel-flarsheim power injectors: angiomat® , illumena® , illumena® néo, ct9000® , ct9000® adv, optistat® , optivantage® and optistar elite. none risk summary administration of sodium chloride injection usp 0.9% is not known to cause major birth defects, miscarriage or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with sodium chloride injection usp 0.9.% all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. risk summary appropriate administration of sodium chloride injection usp 0.9% is not known to cause ha

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - radiology / imaging - the optistar elite injection system is a contrast delivery system and is designed to inject mr contrast media and flushing solutions into a patient’s vascular system to obtain diagnostic images when used with magnetic resonance imaging equipment.

United States - English - NLM (National Library of Medicine)

liebel-flarsheim company llc - iothalamate meglumine (unii: xuw72gop7w) (iothalamic acid - unii:16chd79mix) - iothalamate meglumine 172 mg in 1 ml - cysto-conray ii is indicated for use in retrograde cystography and cystourethrography. see warnings concerning inadvertant intrathecal administration.

United States - English - NLM (National Library of Medicine)

liebel-flarsheim company llc - diatrizoate meglumine (unii: 3x9mr4n98u) (diatrizoic acid - unii:5uvc90j1lk), diatrizoate sodium (unii: v5403h8vg7) (diatrizoic acid - unii:5uvc90j1lk) - diatrizoate meglumine 600 mg in 1 ml - md-gastroview (diatrizoate meglumine and diatrizoate sodium solution) is indicated for radiographic examination of segments of the gastrointestinal tract (esophagus, stomach, proximal small intestine, and colon). the preparation is particularly indicated when a more viscous agent such as barium sulfate, which is not water-soluble, is not feasible or is potentially dangerous. md-gastroview may also be used as an adjunct to contrast enhancement in computed tomography of the torso (body imaging); the preparation is indicated, in conjunction with intravenous admin­istration of a radiopaque contrast agent, when unenhanced imaging may not provide sufficient definition in distinguishing normal loops of bowel from adjacent organs or areas of suspected pathology. do not administer to patients with a known hypersensitivity to md-gastroview or any of its components.

United States - English - NLM (National Library of Medicine)

liebel-flarsheim company llc - iothalamate meglumine (unii: xuw72gop7w) (iothalamic acid - unii:16chd79mix) - iothalamate meglumine 600 mg in 1 ml - conray is indicated for use in excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography. conray may also be used for enhancement of computed tomographic scans performed for detection and evaluation of lesions in the liver, pancreas, kidneys, abdominal aorta, mediastinum, abdominal cavity and retroperitoneal space. continuous or multiple scans separated by intervals of 1 to 3 seconds during the first 30 to 90 seconds post-injection of the contrast medium (dynamic ct scanning) may provide enhancement of diagnostic significance, and may be of benefit in establishing diagnoses of certain lesions in these sites with greater assurance than is possible with ct alone, and in supplying additional features of the lesions. in oth

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - radiology / imaging - the liebel-flarsheim angiomat illumena is designed to inject a radiopaque contrast medium into the vascular system for angiographic or ct procedures as prescribed by qualified healthcare professionals. contraindications for the use of this device are determined by the prescribing physician at the time of use based upon the contrast media package inserts.

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - radiology / imaging - the liebel-flarsheim ct 9000 adv injector is designed to inject a radiopaque contrast media into a patient’s vascular system, which enhances diagnostic images obtained with computed tomography (i.e. ct). each injection is accomplished with a motor driven syringe mechanism with microprocessor control of the flow rate, volume and timing.

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - radiology / imaging - the liebel-flarsheim ct 9000 adv / optibolus injection system is designed to inject a radiopaque contrast media into a patient’s vascular system, which enhances diagnostic images obtained with computed tomography (i.e. ct). each injection is accomplished with a motor driven syringe mechanism with microprocessor control of the flow rate, volume and timing. the optibolus feature is used to enable an exponential decaying flow rate injection that will optimize the contrast usage and provide an extended period of uniform enhancement. the optibolus feature can be tuned on or off by the user for any given injection protocol.

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - radiology / imaging - the liebel-flarsheim optistat injector is designed to inject a radiopaque contrast media into a patient’s vascular system, which enhances diagnostic images obtained with x-ray procedures. each injection is accomplished with a motor driven syringe mechanism with microprocessor control of the flow rate, volume and timing. contraindications for the use of this device are determined by the prescribing physician at the time of use and upon the contrast media package inserts.

Singapore - English - HSA (Health Sciences Authority)

angeion medical international pte. ltd. - radiology / imaging - the ready-box contrast media warmer is intended to warm contrast media to approximately body temperature before injection.